logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12214048 B1

PDFFull Text
Date of Patent:
Feb. 04, 2025

Filed:

Jan. 05, 2022

Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for use in medicine

Applicant:

Amal Therapeutics SA, Geneva, CH;

Inventors:

Madiha Derouazi, Grand-Saconnex, CH;

Elodie Belnoue, Geneva, CH;

Assignee:

AMAL THERAPEUTICS SA, Geneva, CH;

Attorney:

Harness Dickey & Pierce P.L.C.

Primary Examiner:

Bridget E Bunner

Int. Cl.
CPC ...
C07K 7/06 (2006.01); A61K 38/10 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 47/42 (2017.01); A61K 47/64 (2017.01); A61K 47/66 (2017.01); A61P 35/00 (2006.01); C07K 2/00 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C07K 14/475 (2006.01); C07K 16/22 (2006.01); C07K 16/28 (2006.01); C07K 19/00 (2006.01); C12N 15/62 (2006.01);
U.S. Cl.
CPC ...
A61K 47/66 (2017.08); A61K 38/17 (2013.01); A61K 38/18 (2013.01); A61K 39/00 (2013.01); A61K 39/0011 (2013.01); A61K 39/3955 (2013.01); A61K 39/464416 (2023.05); A61K 47/42 (2013.01); A61K 47/64 (2017.08); A61K 47/642 (2017.08); A61K 47/6425 (2017.08); A61P 35/00 (2018.01); C07K 2/00 (2013.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/475 (2013.01); C07K 16/2818 (2013.01); C07K 16/2863 (2013.01); C07K 16/2878 (2013.01); C07K 19/00 (2013.01); C12N 15/625 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55572 (2013.01); C07K 2317/75 (2013.01); C07K 2317/76 (2013.01); C07K 2319/10 (2013.01); C07K 2319/40 (2013.01);
Abstract

The present invention provides a combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, at least one antigen or antigenic epitope, and a TLR peptide agonist for use in medicine, in particular in the prevention and/or treatment of cancer. Moreover, the present invention also provides compositions, such as a pharmaceutical compositions and vaccines, which are useful in medicine, for example in the prevention and/or treatment of cancer.

Find Patent Forward Citations

Derouazi, Madiha. (2025). Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for use in medicine (U.S. Patent No. 12214048). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12214048

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…